Bioadhesive properties of Gantrez nanoparticles

被引:58
作者
Irache, JM [1 ]
Huici, M [1 ]
Konecny, M [1 ]
Espuelas, S [1 ]
Campanero, MA [1 ]
Arbos, P [1 ]
机构
[1] Univ Navarra, Ctr Galenico, E-31080 Pamplona, Spain
关键词
nanoparticles; bioadhesion; Gantrez; oral administration;
D O I
10.3390/10010126
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bioadhesive nanoparticles have been proposed as carriers for the oral delivery of poorly available drugs and facilitate the use of this route. This work summarises some experiments describing the bioadhesive potential of Gantrez nanoparticles fluorescently labeled with rhodamine B isothiocyanate. The adhesive potential of Gantrez was found to be stronger when folded as nanoparticles than in the solubilised form. Conventional nanoparticles displayed a tropism for the upper areas of the gastrointestinal tract, with a maximum of adhesion 30 min post-administration and a decrease in the adhered fraction along the time depending on the given dose. The cross-linkage of nanoparticles with increasing amounts of 1,3-diaminopropane stabilised the resulting carriers and prolonged their half-life in an aqueous environment; although, the adhesive capacity of nanoparticles, the intensity and the relative duration of the adhesive interactions within the gut as a function of the cross-linking degree. Finally, nanoparticles were coated with either gelatin or albumin. In the first case, the presence of gelatin dramatically decreased the initial capacity of these carriers to interact with the gut mucosa and the intensity of these phenomenons. In the latter, bovine serum albumin coated nanoparticles (BSA-NP) showed an important tropism for the stomach mucosa without further significant distribution to other parts of the gut mucosa.
引用
收藏
页码:126 / 145
页数:20
相关论文
共 66 条
[1]  
AKINLOCH AJ, 1980, J MATER SCI, V15, P2141
[2]   Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites [J].
Akiyama, Y ;
Nagahara, N ;
Nara, E ;
Kitano, M ;
Iwasa, S ;
Yamamoto, I ;
Azuma, J ;
Ogawa, Y .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (02) :159-166
[3]   IN-VITRO AND IN-VIVO EVALUATION OF MUCOADHESIVE MICROSPHERES PREPARED FOR THE GASTROINTESTINAL-TRACT USING POLYGLYCEROL ESTERS OF FATTY-ACIDS AND A POLY(ACRYLIC ACID) DERIVATIVE [J].
AKIYAMA, Y ;
NAGAHARA, N ;
KASHIHARA, T ;
HIRAI, S ;
TOGUCHI, H .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :397-405
[4]   IN-VITRO EXTENDED-RELEASE PROPERTIES OF DRUG-LOADED POLY(DL-LACTIC ACID) NANOPARTICLES PRODUCED BY A SALTING-OUT PROCEDURE [J].
ALLEMANN, E ;
LEROUX, JC ;
GURNY, R ;
DOELKER, E .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1732-1737
[5]   THE TRANSPORT OF MICROSPHERES FROM THE GASTROINTESTINAL-TRACT TO INFLAMMATORY AIR POUCHES IN THE RAT [J].
ALPAR, HO ;
FIELD, WN ;
LEWIS, DA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (03) :194-196
[6]  
[Anonymous], 1993, CHEM SULPHUR CONTAIN
[7]   Bioadhesive potential of gliadin nanoparticulate systems [J].
Arangoa, MA ;
Ponchel, G ;
Orecchioni, AM ;
Renedo, MJ ;
Duchêne, D ;
Irache, JM .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 (04) :333-341
[8]   Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics [J].
Arangoa, MA ;
Campanero, MA ;
Renedo, MJ ;
Ponchel, G ;
Irache, JM .
PHARMACEUTICAL RESEARCH, 2001, 18 (11) :1521-1527
[9]   Uptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats:: modification of the body distribution after suspension in surfactant solutions and in oil vehicles [J].
Araujo, L ;
Sheppard, M ;
Löbenberg, R ;
Kreuter, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 176 (02) :209-224
[10]   Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines [J].
Arbós, P ;
Campanero, MA ;
Arangoa, MA ;
Irache, JM .
JOURNAL OF CONTROLLED RELEASE, 2004, 96 (01) :55-65